Literature DB >> 23238968

Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.

Andrew B Rosenkrantz1, Hersh Chandarana, Anthony Gilet, Fang-Ming Deng, James S Babb, Jonathan Melamed, Samir S Taneja.   

Abstract

PURPOSE: To assess the utility of diffusion-weighted imaging (DWI) findings as an indirect marker of side-specific risk of extracapsular extension (ECE) of prostate cancer.
MATERIALS AND METHODS: Fifty-one patients underwent 3T magnetic resonance imaging (MRI) before prostatectomy. Radiologists 1 and 2 (4 and 1 years experience) assessed each side for ECE using T2-weighted imaging (T2WI) and evaluated apparent diffusion coefficient (ADC) maps for the presence of apparent tumor in each lobe and to measure peripheral zone ADC. A uropathologist measured the extent of any ECE.
RESULTS: In all, 28/102 lobes had ECE, of which 12 measured ≤1 mm, 11 measured >1 mm and ≤2 mm, and five measured >2 mm. Side-specific accuracies for detection of ECE for readers 1 and 2 were respectively: T2WI 68.6% and 74.5%; presence of apparent tumor on ADC map 66.7% and 60.8%; ADC value 75.5% and 69.6%. For ECE >2 mm, both readers achieved 100% sensitivity based on apparent tumor on ADC map or ADC values and 80% sensitivity using T2WI. For detection of ECE ≤2 mm, sensitivity for all combinations of the three methods and two readers ranged from 58.3%-81.8%, aside from assessment for ECE using T2WI by the less experienced reader, which exhibited sensitivity of 17.4%. Interreader agreement for the presence of ECE was 0.18 using T2WI, 0.37 using apparent tumor on ADC map, and 0.60 using ADC values.
CONCLUSION: Compared with T2WI, DWI had comparable accuracy for side-specific assessment of ECE, greater sensitivity for ECE <2 mm for the less-experienced radiologist, and greater interreader agreement.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  MRI; apparent diffusion coefficient; diffusion-weighted imaging; extracapsular extension; prostate cancer; staging

Mesh:

Year:  2012        PMID: 23238968     DOI: 10.1002/jmri.23972

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  11 in total

Review 1.  Imaging and evaluation of patients with high-risk prostate cancer.

Authors:  Marc A Bjurlin; Andrew B Rosenkrantz; Luis S Beltran; Roy A Raad; Samir S Taneja
Journal:  Nat Rev Urol       Date:  2015-10-20       Impact factor: 14.432

2.  Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.

Authors:  Ayumu Kido; Tsutomu Tamada; Teruki Sone; Naoki Kanomata; Yoshiyuki Miyaji; Akira Yamamoto; Katsuyoshi Ito
Journal:  Radiol Med       Date:  2016-12-09       Impact factor: 3.469

3.  Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology.

Authors:  Lars Boesen; Elizaveta Chabanova; Vibeke Løgager; Ingegerd Balslev; Kari Mikines; Henrik S Thomsen
Journal:  Eur Radiol       Date:  2014-12-11       Impact factor: 5.315

4.  A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient.

Authors:  Erik Rud; Lien Diep; Eduard Baco
Journal:  World J Urol       Date:  2018-01-18       Impact factor: 4.226

5.  Accuracy of multiparametric magnetic resonance imaging for detecting extracapsular extension in prostate cancer: a systematic review and meta-analysis.

Authors:  Fan Zhang; Chen-Lu Liu; Qian Chen; Sheng-Chao Shao; Shuang-Qing Chen
Journal:  Br J Radiol       Date:  2019-10-16       Impact factor: 3.039

6.  Multi-parametric MRI of the prostate: Factors predicting extracapsular extension at the time of radical prostatectomy.

Authors:  Geoffrey S Gaunay; Vinay Patel; Paras Shah; Daniel Moreira; Ardeshir R Rastinehad; Eran Ben-Levi; Robert Villani; Manish A Vira
Journal:  Asian J Urol       Date:  2016-11-19

7.  Three-dimensional nuclear magnetic resonance spectroscopy: a complementary tool to multiparametric magnetic resonance imaging in the identification of aggressive prostate cancer at 3.0T.

Authors:  Michael Deal; Florian Bardet; Paul-Michael Walker; Mathilde Funes de la Vega; Alexandre Cochet; Luc Cormier; Imad Bentellis; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2021-08

8.  Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis.

Authors:  Sungmin Woo; Soleen Ghafoor; Anton S Becker; Sangwon Han; Andreas G Wibmer; Hedvig Hricak; Irene A Burger; Heiko Schöder; Hebert Alberto Vargas
Journal:  Eur J Hybrid Imaging       Date:  2020-09-09

9.  Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer.

Authors:  Erik Rud; Dagmar Klotz; Kristin Rennesund; Eduard Baco; Truls Erik Bjerklund Johansen; Lien My Diep; Aud Svindland; Lars Magne Eri; Heidi B Eggesbø
Journal:  World J Urol       Date:  2014-07-25       Impact factor: 4.226

10.  Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy.

Authors:  Alfonso Gomez-Iturriaga; Juanita Crook; Francisco Casquero; Claudia Carvajal; Arantxa Urresola; Begoña Canteli; Ana Ezquerro; Eduardo Hortelano; Jon Cacicedo; Jose Maria Espinosa; Fernando Perez; Pablo Minguez; Pedro Bilbao
Journal:  J Contemp Brachytherapy       Date:  2014-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.